---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043213"
form_type: "8-K"
ticker: "INVU"
cik: "0000862651"
company_name: "Investview, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:51:31.573076+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Investview acquires Renu Labs and repurchases 121M shares (6.5% of outstanding)

## Summary
- Acquired Renu Laboratories, a manufacturer of proprietary health/beauty/wellness products; terms not disclosed.
- Expects acquisition to be revenue accretive as early as Q4 2024 - Q1 2025 via iGenius cross-selling.
- Repurchased 121M shares (6.5% of outstanding) from three non-affiliate shareholders at a discount to closing price.
- Repurchase resolves a dispute related to 2017 issuance; price payable in 10 equal quarterly installments.
- Plans to operate Renu under new myLife Wellness business unit leveraging its FDA-registered, cGMP facility.

## SEC filing metadata
- accession: 0001493152-24-043213
- form_type: 8-K
- ticker: INVU
- cik: 0000862651
- company_name: Investview, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862651/000149315224043213/0001493152-24-043213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862651/000149315224043213/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043213
- JSON: https://secwatch.observer/filing/0001493152-24-043213.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.